A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 12.365 USD 1.27%
Market Cap: 3.9B USD

Operating Margin
Amneal Intermediate Inc

12.3%
Current
11%
Average
6.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
12.3%
=
Operating Profit
361.5m
/
Revenue
2.9B

Operating Margin Across Competitors

No Stocks Found

Amneal Intermediate Inc
Glance View

Market Cap
3.9B USD
Industry
Pharmaceuticals

Amneal Intermediate Inc. operates as a vital player within the pharmaceutical industry, bringing a unique blend of agility and scale to its business operations. Formed from the merger of Amneal Pharmaceuticals LLC and Impax Laboratories, the company has established a broad footprint in both generic and specialty pharmaceuticals. Amneal leverages its extensive manufacturing capabilities to produce a diverse portfolio of generic medications, which is not only cost-effective for patients but also represents a significant revenue stream. Its strategic approach lies in launching high-barrier-to-entry generics, ensuring that the products have minimal competition in the market. This strategy not only helps in capturing market share swiftly but also supports better pricing power. Alongside its robust generics division, Amneal invests substantially in its specialty segment. This arm of the company focuses on developing branded pharmaceuticals, particularly in therapeutic areas such as central nervous system disorders, endocrinology, and oncology. By placing strategic bets on these high-growth areas, Amneal aims to capture another layer of the lucrative pharmaceutical market. Its knack for identifying unmet medical needs and bringing timely, effective treatments to market highlights the company's commitment to innovation and patient care. Together, the combination of high-volume generic production and targeted specialty drug development creates a well-rounded business model designed to drive sustainable growth in a competitive industry.

AMRX Intrinsic Value
19.143 USD
Undervaluation 35%
Intrinsic Value
Price
A
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
12.3%
=
Operating Profit
361.5m
/
Revenue
2.9B
What is the Operating Margin of Amneal Intermediate Inc?

Based on Amneal Intermediate Inc's most recent financial statements, the company has Operating Margin of 12.3%.

Back to Top